$FRMI

Today’s top U.S. stock movers: Fermi, NIQ and others surge on AI and biotech catalysts

Investing.com reports major U.S. stock movers, led by FRMI up 22.2% on an AI campus lease and potential revenue expansion, ALMR up 28.3% after launching an immune profiling panel, and Hertz up 24.5% on index removal and heavy options activity. Other gainers include Septerna, Rapid7, Kopin, and NextNav, with catalysts tied to AI, biotech, and earnings.

Original reporting
Published Aug 11, 2026, 6:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 6:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$FRMI
Bullish
low confidence
Mentioned
$FRMI · $ALMR · $KOPN · $RPD · $NN · $COMP
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$FRMIBullishLow
01

Why it matters

The only actionable edge is identifying which tickers are tied to same-day company-specific catalysts versus flow-driven moves; however, the scrape lacks verification details for several claims.

02

Market read

This is a catalyst-driven mover list rather than a single-company fundamental update; it is most useful for short-term momentum and volatility management.

03

What to watch

The scrape does not provide primary sources (filings, contract terms, trial endpoints, or guidance numbers) for several catalysts, so traders should verify before sizing.

Relevance 4/10Novelty 3/10Timing: today’s intraday U.S. stock-mover snapshot

Background

The article is a daily U.S. market wrap focused on top gainers, attributing moves to AI, energy, biotech catalysts, and some speculation-driven trading.

Company-level read

Ticker impact

$FRMIBullishLow confidence
Context

FRMI is cited as up 22.2% on an alleged $6.5B AI campus lease that could expand contracted revenue.

Expected impact

Near-term upside bias with elevated volatility; follow-through depends on lease confirmation and expansion terms.

Evidence & confidence

The article attributes the move to a large AI lease and frames potential revenue expansion, but provides no primary filing, contract terms, or verification.

$ALMRBullishMedium confidence
Context

ALMR is listed as up 28.3% after launching a new immune profiling panel expanding its biotech offering.

Expected impact

Likely continued strength if investors treat the panel as incremental revenue and adoption accelerates.

Evidence & confidence

The text links the gain to a specific product launch, which is a concrete company-specific catalyst even without financial figures.

$KOPNNeutralLow confidence
Context

Kopin (KOPN) is up 21.1% and the article says insider activity is reported, fueling speculative action.

Expected impact

Short-term volatility likely persists; conviction depends on the nature and size of the insider transaction.

Evidence & confidence

The scrape mentions insider activity but does not specify transaction type, size, or filing source, limiting signal quality.

$RPDNeutralMedium confidence
Context

Rapid7 (RPD) is up 18.7% after an earnings beat with a neutral outlook mentioned in the article.

Expected impact

Moderate upside bias initially, with risk of pullback if investors focus on the neutral outlook.

Evidence & confidence

The text provides a clear earnings-beat catalyst and notes outlook neutrality, which is actionable for near-term positioning.

$NNNeutralLow confidence
Context

NextNav (NN) is up 16.7% and the article attributes the move to location-tech news with modest guidance.

Expected impact

Choppy trading; upside continuation possible but likely capped without stronger guidance.

Evidence & confidence

The scrape does not provide the specific guidance numbers or the exact news item beyond broad framing.

$COMPNeutralLow confidence
Context

Compass Diversified (COMP) is up 12.4% and the article frames it as a dividend play and value rebound.

Expected impact

Limited upside unless there is a fresh capital return or earnings catalyst not included in the scrape.

Evidence & confidence

The catalyst is narrative-based (dividend play, value rebound) with no concrete new corporate action described.

Market effects

AI and biotech names are highlighted as leading movers, reinforcing a near-term risk-on rotation into catalyst-driven small and mid caps.

Primarily U.S.-centric flow story; no direct cross-market transmission details provided beyond general volatility.

No explicit global macro or international policy linkage beyond a brief mention of Hormuz reopening jitters.

Counterpoint

Some of the biggest movers appear driven by positioning (index removal, options activity) or vague “insider activity” rather than verifiable fundamentals, increasing mean-reversion risk.

Key entities

  • Fermi Inc.

    Named as the top mover, up 22.2% on an alleged $6.5B AI campus lease and potential revenue expansion.

  • ALMR

    Named as a biotech product-launch winner, up 28.3% on a new immune profiling panel.

  • Hertz Global Holdings, Inc.

    Named as a high-volatility mover, up 24.5% on index removal and options activity.

  • Rapid7 Inc

    Named as an earnings-beat winner, up 18.7% with neutral outlook mentioned.

Related articles

$RPDMed

Why Rapid7 (RPD) Shares Are Falling Today

Rapid7 (RPD) shares fell 3.6% after JPMorgan downgraded the stock to Underweight with a $12.00 price target, citing operational challenges and unwarranted recent gains. The stock later recovered slightly to $12.52, down 2.2%. Rapid7's shares are down 12.3% YTD and 39.9% below their 52-week high.

$FRMIHighAI 8/10

FRMI Stock Sinks 18% After-Hours — Fermi Launches $350M Convertible Notes Offering

Fermi LLC (FRMI) shares fell 18% after-hours on Thursday after announcing a $350M convertible notes offering due 2031, with an option for $52.5M more. Proceeds will fund capped call transactions and general corporate purposes. The notes are senior unsecured obligations convertible into cash, stock, or both. The company expects to use proceeds to offset potential share dilution. FRMI stock is down 1.74% year-to-date.

$FRMIMed

Largest Fermi (FRMI) shareholder group presses for deal review

Fermi Inc.'s (FRMI) largest shareholder, Vicksburg Investments, filed a proposal for an independent review of strategic options. The shareholder group, owning 22% of shares, seeks an investment bank to evaluate potential transactions. Fermi's stock has fallen 20% since the board's August 13 announcement and 35% since July 2. The shareholder also requested changes to voting standards and ownership limits.

$RPDHighAI 9/10

Why is Rapid7 stock surging today?

Rapid7 stock surged 13.2% after reporting better-than-expected Q2 2026 results, raising full-year EPS guidance by 15.7% to $1.81. Analysts increased price targets, with Citi at $13 and Susquehanna at $15. The company announced a 12% workforce reduction and expects $130M in free cash flow. The broader market's risk-on sentiment also supported the rise.

$COMPMed

Tribeca tenants blame $5K rents on nation's largest brokerage in new federal complaint

A federal class-action lawsuit accuses Compass, the nation's largest real estate brokerage, of monopolizing 80% of Manhattan rentals and inflating prices by hiding listings. Tenants claim they pay $5,270/month for one-bedroom apartments due to Compass' actions. Compass faces multiple investigations and lawsuits over market practices. Manhattan's median rent hit a record $5,000 last month, with only 1.4% of apartments available.